| ►From 1988 to 1999 | ►From 1999 to 2003 | ||
| ►From 2003 to 2005 |
--------------------------------------------------------------------------------------------------------------------------------------------- |
|
March 1988
|
The company was funded by Huidong Fu, Weibing Wang, Siming, Lee, Lizhi Luo, Meihui, Liao, and was located on 8F, No 293-3, Section 2, Fusing South Road, Taipei City, and named Enfield Medical Supply with capital of NT$ 5,000,000. It specialized in medical supply business with focus in products for hemodialysis and imports, such as artificial anus and colostomy. |
---------------------------------------------------------------------------------------------------------------------------------------------
|
|
March 1989
|
In responding to the increasing orders, Enfield Medical Supply was changed to ENFIELD MEDICAL CO., LTD. |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
June 1991
|
The company’s capital was increased to NT$65milion. |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
February 1992
|
Purchased Taichung office, expanded the marketing business, and built a maintenance system in the central area. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
May 1996
|
Purchased Kaohsiung office, expanded the marketing business, and built a maintenance system in the southern area. |
---------------------------------------------------------------------------------------------------------------------------------------------
|
|
January 1997
|
Completed internet structure, and the trend of management entered into e-era. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
February 1997
|
The company’s capital was increased to NT $160,000,000. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
October 1997
|
Siming, Lee was named the Chairman. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
November 1997
|
In respond to business demand, the company relocated to F16, No. 57, Fusing North Road, Taipei. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
April 1998
|
1. The board of directors reassembled, and Mr. Siming Lee, corporate representative and director at Chia He Investment Co., Ltd., was elected the Chairman. 2.The authorized capital was NT$600million, and prepared capital increase by cash to NT$1.1 million, so that the paid-up capital reached NT$300 million, and to be listed publicly. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
June 1998
|
The company entered globalization era, and formed alliance with RTS Worldwide Holding Inc, a subsidiary company of Baxter International, and established “RTS Excelsior Co., Ltd” to expand and manage hemodialysis related business. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
July 1998
|
The company was approved by Securities and Future Commission, Ministry of Finance to be a public listing company to increase management performance. |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
May 1999
|
1. Attained exclusive right for hemodialysis product in Taiwan from Baxter International of US. 2.Attained exclusive right for blood bag products from JMS of Japan. |
| --------------------------------------------------------------------------------------------------------------------------------------------- | |
